Ju Y - Search Results

1

Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer.

Gao M, Zhang X, Yan H, Sun D, Yang X, Yuan F, Ju Y, Wang L, Wang J, Zhao W, Zhang D, Li L, Xu X, Ma J, Hu Y, Zhang X. Gao M, et al. Among authors: ju y. Support Care Cancer. 2023 Nov 4;31(12):671. doi: 10.1007/s00520-023-08125-3. Support Care Cancer. 2023. PMID: 37924363 Free PMC article.

2

Mutation of the Nrf2 gene in non-small cell lung cancer.

Hu Y, Ju Y, Lin D, Wang Z, Huang Y, Zhang S, Wu C, Jiao S. Hu Y, et al. Among authors: ju y. Mol Biol Rep. 2012 Apr;39(4):4743-7. doi: 10.1007/s11033-011-1266-4. Epub 2011 Oct 1. Mol Biol Rep. 2012. PMID: 21964605

3

Clinicopathological features and prognosis of pseudomyxoma peritonei.

Wang H, Wang X, Ju Y, Wang J, Zhang X, Cheng Y, Sun J, Hu Y. Wang H, et al. Among authors: ju y. Exp Ther Med. 2014 Jan;7(1):185-190. doi: 10.3892/etm.2013.1408. Epub 2013 Nov 13. Exp Ther Med. 2014. PMID: 24348787 Free PMC article.

4

Toxicity and adverse effects of everolimus in the treatment of advanced nonsmall cell lung cancer pretreated with chemotherapy--Chinese experiences.

Ju Y, Hu Y, Sun S, Wang J, Jiao S. Ju Y, et al. Indian J Cancer. 2015 Nov;52 Suppl 1:e32-6. doi: 10.4103/0019-509X.168954. Indian J Cancer. 2015. PMID: 26548937 Free article.

5

Prolonged overall survival of patients with leptomeningeal carcinomatosis from nonsmall cell lung cancer.

Ju Y, Sun S, Wang J, Jiao S. Ju Y, et al. J Cancer Res Ther. 2016 Oct;12(Supplement):126-129. doi: 10.4103/0973-1482.191638. J Cancer Res Ther. 2016. PMID: 27721269 Free article.

6

Nimotuzumab treatment and outcome analysis in patients with leptomeningeal metastasis from nonsmall cell lung cancer.

Ju Y, Wang J, Sun S, Jiao S. Ju Y, et al. J Cancer Res Ther. 2016 Dec;12(Supplement):C181-C185. doi: 10.4103/0973-1482.200596. J Cancer Res Ther. 2016. PMID: 28230014 Free article.

7

Programmed Cell Death Protein 1 Inhibitor-Mediated Peripheral Neuropathy.

Ao Y, Gao M, Sun B, Hao H, Yan H, Li C, Sun D, Yang X, Ju Y, Zhang X, Ma J. Ao Y, et al. Among authors: ju y. JTO Clin Res Rep. 2023 Mar 7;4(4):100495. doi: 10.1016/j.jtocrr.2023.100495. eCollection 2023 Apr. JTO Clin Res Rep. 2023. PMID: 37095750 Free PMC article. Review.

8

Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trial.

Gao M, Zhang X, Yan H, Zhao Y, Yuan F, Sun D, Yang X, Ju Y, Wang L, Tao H, Tian L, Zhao C, Ma J, Hu Y, Liu Z. Gao M, et al. Among authors: ju y. Ther Adv Med Oncol. 2025 Jan 1;17:17588359241311058. doi: 10.1177/17588359241311058. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 39759826 Free PMC article.

9

[Expression and clinical significance of CD3, CD4 and COX-2 in non-small cell lung cancer].

Zhao X, Yan X, Ju YF, Yu HM, Jiao SC. Zhao X, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Apr;28(4):407-9. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012. PMID: 22482414 Chinese.

10

Prolonged overall survival in metastatic gastric cancer treated with ipilimumab and lapatinib.

Ju Y, Sun S, Jiao S. Ju Y, et al. J Cancer Res Ther. 2018;14(7):1589-1593. doi: 10.4103/jcrt.JCRT_508_17. J Cancer Res Ther. 2018. PMID: 30589044 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,056 results

Search Page

Filters